These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 311881)

  • 1. Cellular immunity in patients with epidermoid cancer of the head and neck.
    Papenhausen PR; Kukwa A; Croft CB; Borowiecki B; Silver C; Emeson EE
    Laryngoscope; 1979 Apr; 89(4):538-49. PubMed ID: 311881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of combined immunotherapy with levamisole and Bacillus Calmette-Guérin on immunocompetence of patients with squamous cell carcinoma of the cervix, head and neck, and lung undergoing radiation therapy.
    Olkowski ZL; McLaren JR; Skeen MJ
    Cancer Treat Rep; 1978 Nov; 62(11):1651-61. PubMed ID: 310339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological status of patients in carcinoma head and neck.
    Vasenwala SM; Aziz M; Rattan A; Ahmad KN
    Indian J Cancer; 1989 Sep; 26(3):137-44. PubMed ID: 2630426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An immunological outcome predictive score for head and neck carcinoma patients.
    Kaffenberger W; Hölzer-Müller L; Auberger T; Clasen BP; Hohlmeier G; van Beuningen D
    Strahlenther Onkol; 1995 Aug; 171(8):444-53. PubMed ID: 7652667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transference of cell mediated immunity in patients with head and neck cancer.
    Vetto RM; Burger DR
    Laryngoscope; 1978 Jan; 88(1 Pt 2 Suppl 8):79-82. PubMed ID: 304143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of thymosin and irradiation on immune modulation in head and neck and esophageal cancer patients.
    Wara WM; Ammann AJ; Wara DW
    Cancer Treat Rep; 1978 Nov; 62(11):1775-8. PubMed ID: 728896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active T-rosette-forming cells in the peripheral blood of cancer patients.
    Kerman RH; Smith R; Stefani SS; Ezdinili EZ
    Cancer Res; 1976 Sep; 36(9 pt.1):3274-8. PubMed ID: 1086131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unspecific cellular immunity before therapy in patients with squamous cell carcinoma of head and neck.
    Bier J; Bitter K; Nicklisch U
    J Maxillofac Surg; 1978 May; 6(2):75-93. PubMed ID: 353210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of activated T lymphocytes in peripheral blood of head and neck squamous cell carcinoma patients predicts impaired prognosis.
    Aarstad HJ; Heimdal JH; Klementsen B; Olofsson J; Ulvestad E
    Acta Otolaryngol; 2006 Dec; 126(12):1326-33. PubMed ID: 17101596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levamisole in squamous cell carcinoma of the head and neck.
    Olivari AJ; Glait HM; Guardo A; Califano L; Pradier R
    Cancer Treat Rep; 1979 Jun; 63(6):983-90. PubMed ID: 380804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot clinical trial of the toxicity and immunorestorative effects of T cell reconstituting factor (SR 270258) in immunosuppressed cancer patients.
    Murray JL; Reuben JM; Smith TL; Gehan EA; Koretz SM; Hersh EM
    J Biol Response Mod; 1987 Feb; 6(1):56-68. PubMed ID: 2951501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A correlative analysis of in vitro parameters of cellular immunity in patients with squamous cell carcinoma of the head and neck.
    Deegan MJ; Coulthard SW; Quaiman SJ; Schork MA
    Cancer Res; 1977 Dec; 37(12):4475-81. PubMed ID: 144562
    [No Abstract]   [Full Text] [Related]  

  • 13. The relationship of circulating IgA to cellular immunity in head and neck cancer patients.
    Schantz SP; Liu FJ; Taylor D; Beddingfield N; Weber RS
    Laryngoscope; 1988 Jun; 98(6 Pt 1):671-8. PubMed ID: 3259661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymostimulin enhancement of T-cell infiltration into head and neck squamous cell carcinoma.
    Kerrebijn JD; Simons PJ; Balm AJ; Tas M; Knegt PP; de Vries N; Tan IB; Drexhage HA
    Head Neck; 1996; 18(4):335-42. PubMed ID: 8780944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune reactivity in primary carcinoma of the lung and its relation to prognosis.
    Wanebo HJ; Rao B; Miyazawa N; Martini N; Middleman MP; Oettgen HF; Beattie EJ
    J Thorac Cardiovasc Surg; 1976 Sep; 72(3):339-50. PubMed ID: 183063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gamma-delta T-cells in patients with squamous cell carcinoma of the head and neck.
    Bas M; Bier H; Schirlau K; Friebe-Hoffmann U; Scheckenbach K; Balz V; Whiteside TL; Hoffmann TK
    Oral Oncol; 2006 Aug; 42(7):691-7. PubMed ID: 16527515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cellular immunity indices in benign breast tumors].
    Baisheva SA; Zhalgasbaeva GT; Kaliev IuSh; Mezinova NN
    Vopr Onkol; 1980; 26(5):15-9. PubMed ID: 7385708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune reactivity in head and neck squamous carcinoma and relevance to the design of immunotherapy trials.
    Browder JP; Chretien PB
    Semin Oncol; 1977 Dec; 4(4):431-9. PubMed ID: 339354
    [No Abstract]   [Full Text] [Related]  

  • 19. Some aspects of cell-mediated hypersensitivity in patients with melanoma.
    Moszkowska G; Jassem J; Kondrat W; Kopacz A; Goszczyńska E
    Arch Immunol Ther Exp (Warsz); 1980; 28(4):655-60. PubMed ID: 6970028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical evaluation of lymphocyte functions in urological cancer patients.
    Elhilali MM; Paika KD; Brosman S; Fahey JL
    Cancer Res; 1976 Jan; 36(1):132-7. PubMed ID: 1082369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.